Publication: Synthesis, DFT, electrochemical, biological and DNA-interaction studies of a novel copper(II) complex of salicylic acid and N-tosyl substituted benzimidazole
dc.contributor.author | Rashid, N | en_US |
dc.contributor.author | Kiran, A | en_US |
dc.contributor.author | Ahmad, I | en_US |
dc.contributor.author | Ashraf, Z | en_US |
dc.contributor.author | Yamin, BM | en_US |
dc.contributor.author | Rafiq, M | en_US |
dc.date.accessioned | 2024-05-29T02:55:59Z | |
dc.date.available | 2024-05-29T02:55:59Z | |
dc.date.issued | 2020 | |
dc.description.abstract | Sulfonylbenzimidazoles and their copper complexes have tremendous applications in drug development. In the present work, bis(2-hydroxylbenzoato-kappa O-2,O ')bis(2-methyl-1-(toluene-4-sulfonyl)-1H-benzimidazole) copper(II) complex [Cu(L-1)(L-2)] has been synthesized and structurally characterized by Fourier-transformed infrared spectroscopy (FTIR) and single-crystal X-ray diffraction (XRD). The complex formed a distorted octahedral geometry with the benzimidazole ligands occupying the axial position and the hydroxylbenzoato ligands in the equatorial positions. The latter ligands coordinated in an isobidentate manner with a Cu-O-deprotenated bond length of 1.955(18) angstrom and a long range Cu-O-carbonyl of 2.574(2) angstrom. An excellent correlation was found between bond lengths and bond angles obtained experimentally from single-crystal XRD analysis and that obtained from density functional theory. Electrochemical behavior of [Cu(L-1)(L-2)] has been probed by cyclic voltammetry (CV). CV studies revealed that it undergoes one-electron reduction followed by one-electron oxidation process. In vitro tyrosinase inhibitory activity of the complex was evaluated and it was observed that it exhibited good inhibitory potential with IC50 value 56.8 +/- 11.4 mu M. Complex-DNA-interaction studies were performed by CV, electronic and florescence spectroscopic titrations and it has been inferred that the [Cu(L-1)(L-2)] binds with DNA through intercalation and the value of binding constant was 3.6 x 10(4) M-1. | |
dc.identifier.doi | 10.1080/00958972.2020.1714602 | |
dc.identifier.epage | 66 | |
dc.identifier.isbn | 1029-0389 | |
dc.identifier.issn | 0095-8972 | |
dc.identifier.issue | 1 | |
dc.identifier.scopus | WOS:000508106300001 | |
dc.identifier.spage | 52 | |
dc.identifier.uri | https://oarep.usim.edu.my/handle/123456789/11561 | |
dc.identifier.volume | 73 | |
dc.language | English | |
dc.language.iso | en_US | |
dc.publisher | Taylor & Francis Ltd | en_US |
dc.relation.ispartof | Journal Of Coordination Chemistry | |
dc.subject | Benzimidazole | en_US |
dc.subject | electrochemical | en_US |
dc.subject | density functional theory | en_US |
dc.subject | DNA-interaction | en_US |
dc.subject | copper complex | en_US |
dc.title | Synthesis, DFT, electrochemical, biological and DNA-interaction studies of a novel copper(II) complex of salicylic acid and N-tosyl substituted benzimidazole | |
dc.type | Article | en_US |
dspace.entity.type | Publication |